Valuation GlaxoSmithKline Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. Other stock markets 06:19:08 2026-06-11 EDT			5-day change	1st Jan Change
2,102.70 ^INR	-3.29%		-3.53%	-14.90%

05-29	GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Dr. Simrat Sohal from Compliance Officer and Ceases to Be the Senior Management Personnel, Effective August 5, 2026	CI
05-13	GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit	MT

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	281,714	224,319	329,173	487,432	386,822	356,210	-
Change	-	-20.37%	46.74%	48.08%	-20.64%	-7.91%	-
Enterprise Value (EV)	256,351	207,663	329,173	487,432	386,822	356,210	356,210
Change	-	-18.99%	58.51%	48.08%	-20.64%	-7.91%	0%
P/E Ratio	16.6x	36.7x	55.8x	52.5x	37.3x	31.2x	27.7x
PBR	10.6x	12.9x	18.5x	25x	17.1x	13.4x	11.4x
PEG	-	-0.6x	-16.49x	0.9x	3.2x	3.1x	2.2x
Capitalization / Revenue	8.59x	6.9x	9.53x	13x	10.1x	8.49x	7.67x
EV / Revenue	0x	0x	0x	0x	0x	8.49x	7.67x
EV / EBITDA	0x	0x	0x	0x	0x	24.3x	21.4x
EV / EBIT	0x	0x	0x	0x	0x	25.9x	22.6x
EV / FCF	0x	0x	0x	0x	0x	30.7x	27.7x
FCF Yield	2.75%	1.96%	1.67%	2.6%	2.19%	3.26%	3.61%
Dividend per Share ²	30	32	32	42	57	29.5	29.5
Rate of return	1.8%	2.42%	1.65%	1.46%	2.5%	1.4%	1.4%
EPS ²	100	36.05	34.83	54.76	61.15	67.3	75.97
Distribution rate	30%	88.8%	91.9%	76.7%	93.2%	43.8%	38.8%
Net sales ¹	32,780	32,517	34,537	37,492	38,217	41,939	46,453
EBITDA ¹	8,273	8,043	9,087	11,774	13,092	14,683	16,675
EBIT ¹	7,592	7,385	8,390	11,106	12,428	13,760	15,728
Net income ¹	16,947	6,107	5,900	9,276	10,360	11,402	12,873
Net Debt	-25,363	-16,656	-	-	-	-	-
Reference price ²	1,662.95	1,324.15	1,943.10	2,877.30	2,283.40	2,102.70	2,102.70
Nbr of stocks (in thousands)	169,406	169,406	169,406	169,406	169,406	169,406	-
Announcement Date	5/16/22	5/17/23	5/17/24	5/13/25	5/13/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	32.31x	-	-	1.36%	3.87B
ELI LILLY AND COMPANY	33.25x	12.09x	24.89x	0.6%	1,013B
JOHNSON & JOHNSON	25.49x	5.87x	15.97x	2.24%	574B
ABBVIE INC.	27.54x	6.71x	13.71x	3.05%	397B
ROCHE HOLDING AG	17.38x	4.29x	10.55x	3.1%	324B
ASTRAZENECA PLC	22.74x	4.73x	13.45x	1.85%	280B
NOVARTIS AG	20.72x	5.35x	13x	3.04%	273B
AMGEN INC.	21.96x	5.91x	10.33x	2.99%	182B
NOVO NORDISK A/S	12.52x	4.69x	9.6x	4.01%	194B
GILEAD SCIENCES, INC.	-43.47x	5.27x	29.72x	2.67%	151B
Average	17.04x	6.10x	15.69x	2.49%	339.25B
Weighted average by Cap.	22.67x	7.45x	17.35x	2.12%